Abstract

Summary

This paper discusses the discovery of melanopsin and ipRGCs, which has led to a revolution in our understanding of circadian photoreception, and is beginning to guide scientists into new uses of light for circadian, sleep, and other disorders.
Categories

Categories

Dementia: The paper discusses the use of light therapy in the treatment of senile dementia.
Sleep and insomnia: The paper discusses the use of light therapy in the treatment of various sleep disorders.
Depression: The paper discusses the use of light therapy in the treatment of Seasonal Affective Disorder (SAD) and non-seasonal depression.
Cognitive function and memory: The paper discusses the impact of light on cognitive and psychological problems in shift workers.
Shift work: The paper discusses the use of light therapy in resolving problems associated with shift work.
Jet lag: The paper discusses the use of light therapy in resolving problems associated with intercontinental travel.
Phototherapy: The paper discusses the use of light therapy in the treatment of various disorders.
Lighting Design Considerations: The paper discusses how the discovery of melanopsin and ipRGCs will provide the basis for major changes in future architectural lighting strategies.
Well-being: The paper discusses the use of light therapy in the treatment of various disorders, contributing to overall well-being.
Authors

Author(s)

JP Hanifin, GC Brainard
Publication Date

Publication Year

2007
Citations

Number of Citations

93
Related

Related Publications

View more publications